Regional Health Properties, Inc. (RHEP)
OTCMKTS · Delayed Price · Currency is USD
1.050
-0.050 (-4.55%)
At close: Aug 28, 2026
RHEP Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 80.8 | 52.37 | 17.61 | 15.8 | 30.98 | 26.42 |
Other Revenue | - | - | 0.06 | 0.21 | 0.03 | 0.09 |
| 80.8 | 52.37 | 17.67 | 16.01 | 31.01 | 26.51 | |
Revenue Growth | 210.06% | 196.40% | 10.32% | -48.36% | 16.98% | 59.17% |
Cost of Revenue | 57.13 | 37.77 | 9.44 | 8.57 | 21.07 | 9.92 |
Gross Profit | 23.66 | 14.6 | 8.23 | 7.44 | 9.94 | 16.59 |
Selling, General & Admin | 21.5 | 12.82 | 6 | 6.01 | 9.53 | 10.4 |
Other Operating Expenses | - | - | - | - | 1.97 | 1.07 |
Operating Expenses | 24.24 | 14.88 | 8.06 | 8.26 | 13.91 | 14.06 |
Operating Income | -0.58 | -0.29 | 0.16 | -0.82 | -3.97 | 2.53 |
Interest Expense | -2.49 | -2.67 | -2.71 | -2.75 | -2.53 | -2.67 |
Other Non Operating Income (Expenses) | -0.78 | -1.29 | -0.67 | 0.58 | 4.24 | 0.01 |
EBT Excluding Unusual Items | -3.85 | -4.25 | -3.22 | -2.99 | -2.26 | -0.13 |
Gain (Loss) on Sale of Assets | 2.7 | 2.71 | - | - | -1.42 | - |
Other Unusual Items | 5.22 | 4.91 | - | -0.9 | -3.19 | -1.05 |
Pretax Income | 4.07 | 3.37 | -3.22 | -3.89 | -6.87 | -1.18 |
Earnings From Continuing Operations | 4.07 | 3.37 | -3.22 | -3.89 | -6.87 | -1.18 |
Net Income to Company | 4.07 | 3.37 | -3.22 | -3.89 | -6.87 | -1.18 |
Net Income | 4.07 | 3.37 | -3.22 | -3.89 | -6.87 | -1.18 |
Preferred Dividends & Other Adjustments | -0.35 | 0.33 | - | -43.4 | 9 | 9 |
Net Income to Common | 4.42 | 3.05 | -3.22 | 39.51 | -15.86 | -10.18 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 4 | 3 | 2 | 2 | 2 | 2 |
Shares Outstanding (Diluted) | 4 | 3 | 2 | 2 | 2 | 2 |
Shares Change | 89.62% | 50.97% | -1.01% | 5.69% | 2.42% | 2.73% |
EPS (Basic) | 1.18 | 1.09 | -1.73 | 21.05 | -8.93 | -5.87 |
EPS (Diluted) | 1.18 | 1.09 | -1.73 | 21.05 | -8.93 | -5.87 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -3.94 | -3.13 | 1.41 | 2.75 | -3.88 | 4.77 |
Free Cash Flow Per Share | -1.05 | -1.12 | 0.76 | 1.47 | -2.18 | 2.75 |
Gross Margin | 29.29% | 27.88% | 46.56% | 46.46% | 32.05% | 62.60% |
Operating Margin | -0.71% | -0.55% | 0.91% | -5.13% | -12.80% | 9.56% |
Profit Margin | 5.47% | 5.82% | -18.21% | 246.70% | -51.16% | -38.40% |
Free Cash Flow Margin | -4.88% | -5.97% | 8.00% | 17.20% | -12.50% | 18.00% |
EBITDA | 2.16 | 1.78 | 2.22 | 1.43 | -1.57 | 5.12 |
EBITDA Margin | 2.67% | 3.39% | 12.58% | 8.96% | -5.05% | 19.33% |
D&A For EBITDA | 2.74 | 2.06 | 2.06 | 2.26 | 2.4 | 2.59 |
EBIT | -0.58 | -0.29 | 0.16 | -0.82 | -3.97 | 2.53 |
EBIT Margin | -0.71% | -0.55% | 0.91% | -5.13% | -12.80% | 9.56% |
Revenue as Reported | 81.52 | 53.16 | 18.34 | 17.16 | 35.93 | 26.69 |